These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26902334)

  • 1. Prostate cancer: Multilayered mutation analysis indicates divergent clonal evolution.
    Thoma C
    Nat Rev Urol; 2016 Apr; 13(4):179. PubMed ID: 26902334
    [No Abstract]   [Full Text] [Related]  

  • 2. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.
    Beltran H; Prandi D; Mosquera JM; Benelli M; Puca L; Cyrta J; Marotz C; Giannopoulou E; Chakravarthi BV; Varambally S; Tomlins SA; Nanus DM; Tagawa ST; Van Allen EM; Elemento O; Sboner A; Garraway LA; Rubin MA; Demichelis F
    Nat Med; 2016 Mar; 22(3):298-305. PubMed ID: 26855148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Aberrations Drive Clonal Evolution of Neuroendocrine Tumors.
    Kaushik AK; Sreekumar A
    Trends Endocrinol Metab; 2016 May; 27(5):242-244. PubMed ID: 27037211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary molecular tests for prognosis and treatment guidance for castration-resistant prostate cancer.
    Buonerba C; Di Lorenzo G; Sonpavde G
    Expert Rev Mol Diagn; 2016 Oct; 16(10):1113-1120. PubMed ID: 27665838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Has the Time Arrived for Biomarker-Directed Therapy in Castration-Resistant Prostate Cancer?
    Taplin ME; Balk SP
    JAMA Oncol; 2015 Aug; 1(5):577-9. PubMed ID: 26181796
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood Based Detection of Androgen Receptor Splice Variants in Patients with Advanced Prostate Cancer.
    Antonarakis ES; Luo J
    J Urol; 2016 Dec; 196(6):1606-1607. PubMed ID: 27620214
    [No Abstract]   [Full Text] [Related]  

  • 7. Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity.
    Aggarwal RR; Quigley DA; Huang J; Zhang L; Beer TM; Rettig MB; Reiter RE; Gleave ME; Thomas GV; Foye A; Playdle D; Lloyd P; Chi KN; Evans CP; Lara PN; Feng FY; Alumkal JJ; Small EJ
    Mol Cancer Res; 2019 Jun; 17(6):1235-1240. PubMed ID: 30918106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ASC-J9 for castration-resistant prostate cancer].
    Yamashita S; Arai Y
    Nihon Rinsho; 2014 Dec; 72(12):2126-9. PubMed ID: 25518345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of STAT3 in Prostate Cancer Metastases.
    Don-Doncow N; Marginean F; Coleman I; Nelson PS; Ehrnström R; Krzyzanowska A; Morrissey C; Hellsten R; Bjartell A
    Eur Urol; 2017 Mar; 71(3):313-316. PubMed ID: 27344294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis.
    Liu YN; Yin J; Barrett B; Sheppard-Tillman H; Li D; Casey OM; Fang L; Hynes PG; Ameri AH; Kelly K
    Mol Cell Biol; 2015 Jun; 35(11):1940-51. PubMed ID: 25802280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormone Resistance and Neuroendocrine Differentiation Due to Accumulation of Genetic Lesions during Clonal Evolution of Prostate Cancer].
    Mikhaylenko DS; Efremov GD; Sivkov AV; Zaletaev DV
    Mol Biol (Mosk); 2016; 50(1):34-43. PubMed ID: 27028809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
    Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK
    Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanisms of resistance to CYP17A1 inhibitors in castrate resistant prostate cancer].
    Ripert T; Crouzet S; Ploussard G; De La Taille A; Robert G
    Prog Urol; 2013 Oct; 23 Suppl 1():S16-22. PubMed ID: 24314735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular biology of castration-resistant prostate cancer].
    Doucet L; Terrisse S; Gauthier H; Pouessel D; Le Maignan C; Teixeira L; Culine S
    Bull Cancer; 2015 Jun; 102(6):497-500. PubMed ID: 26028493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoblasts promote castration-resistant prostate cancer by altering intratumoral steroidogenesis.
    Hagberg Thulin M; Nilsson ME; Thulin P; Céraline J; Ohlsson C; Damber JE; Welén K
    Mol Cell Endocrinol; 2016 Feb; 422():182-191. PubMed ID: 26586211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter-Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth.
    Sung SY; Chang JL; Chen KC; Yeh SD; Liu YR; Su YH; Hsueh CY; Chung LW; Hsieh CL
    PLoS One; 2016; 11(4):e0153350. PubMed ID: 27054343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives.
    Hu J; Wang G; Sun T
    Tumour Biol; 2017 May; 39(5):1010428317692259. PubMed ID: 28475016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of microRNAs in the progression of castration-resistant prostate cancer.
    Kojima S; Goto Y; Naya Y
    J Hum Genet; 2017 Jan; 62(1):25-31. PubMed ID: 27278789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer.
    Taneja SS
    J Urol; 2015 Sep; 194(3):704. PubMed ID: 26292859
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism.
    Shih JW; Wang LY; Hung CL; Kung HJ; Hsieh CL
    Int J Mol Sci; 2015 Dec; 16(12):28943-78. PubMed ID: 26690121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.